3216 Gemcitabine-based regimens without high-dose therapy consolidation generated prolonged disease control in refractory or relapsed Hodgkin lymphoma: a single institutional experience. (September 2015) - Shi, Y.; Yang, S.; He, X.; Zhou, L.; Zhou, S.; Dong, M.; Qin, Y.; Liu, P.; Yang, J.; Zhang, C.; Gui, L.